Drug profile · INN
thiothixene hydrochloride
THIOTHIXENE HYDROCHLORIDE
thiothixene hydrochloride (THIOTHIXENE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — thiothixene hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
thiothixene hydrochloride (THIOTHIXENE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is thiothixene hydrochloride?
thiothixene hydrochloride (THIOTHIXENE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for thiothixene hydrochloride?
THIOTHIXENE HYDROCHLORIDE is a marketed brand name for thiothixene hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of thiothixene hydrochloride?
thiothixene hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.